Adherence of gastroenterologists to European Crohn's and Colitis Organisation Consensus on Crohn's disease: A real-life survey in Spain

被引:14
|
作者
Hinojosa, J. [1 ]
Gisbert, J. P. [3 ,4 ]
Gomollon, F. [2 ,4 ]
San Roman, A. Lopez [5 ]
机构
[1] Hosp Manises, Dept Gastroenterol, Valencia, Spain
[2] Univ Zaragoza, Hosp Clin, Dept Gastroenterol, E-50009 Zaragoza, Spain
[3] Hosp Univ La Princesa, Dept Gastroenterol, Inst Invest Sanitaria Princesa IP, Madrid, Spain
[4] CIBEREHD, Madrid, Spain
[5] Hosp Ramon & Cajal, IBDnet, Dept Gastroenterol, E-28034 Madrid, Spain
来源
JOURNAL OF CROHNS & COLITIS | 2012年 / 6卷 / 07期
关键词
Crohn's disease; ECCO clinical guidelines; Inflammatory bowel disease; Questionnaire; INFLAMMATORY-BOWEL-DISEASE; PRACTICE GUIDELINES; INFLIXIMAB; DIAGNOSIS; COSTS; IBD;
D O I
10.1016/j.crohns.2011.12.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: There is no information as to the extent by which Spanish gastroenterologists adhere to Crohn's disease (CD) management guidelines. The objective of this study was to evaluate the degree of adherence of Spanish gastroenterologists to the European Crohn's and Colitis Organisation (ECCO) guidelines and to determine whether differences in adherence exist between gastroenterologists specialized in inflammatory bowel diseases (GSIBDs) and general gastroenterologists (GGs). Methods: This was a prospective, nation-wide, questionnaire-based survey covering aspects related to diagnosis, treatment, follow-up, and safety considered by the physicians in their daily management of CD, as well as demographic traits seen in clinical practice. Results: The overall degree of adherence to guidelines by both GSIBDs and GGs was high. However, the use of imaging techniques in diagnosis, follow-up, and in relapsed patients differed between the two groups. In the diagnosis of perianal disease, GSIBDs used magnetic resonance and surgical exploration under anesthesia more frequently than GGs. In terms of therapeutic choices, the adherence to guidelines was good in both groups. However, GSIBDs showed significantly higher adherence in some areas: thiopurines were used less in refractory cases and methotrexate was used more commonly in corticoid-dependent, azathioprine-intolerant patients, and in patients under biological treatment. Request for infection studies and vaccinations at diagnosis or prior to treatment was more common among GSIBDs. Conclusions: Guideline adherence among Spanish gastroenterologists is high. However, there are significant differences between IBD-specialized (more adherent in general) and non-specialized gastroenterologists. (C) 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:763 / 770
页数:8
相关论文
共 50 条
  • [1] Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: A real-life survey in Spain
    Gisbert, J. P.
    Gomollon, F.
    Hinojosa, J.
    Lopez San Roman, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2010, 4 (05): : 567 - 574
  • [2] European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease
    Rieder, Florian
    Latella, Giovanni
    Magro, Fernando
    Yuksel, Elif S.
    Higgins, Peter D. R.
    Di Sabatino, Antonio
    de Bruyn, Jessica R.
    Rimola, Jordi
    Brito, Jorge
    Bettenworth, Dominik
    van Assche, Gert
    Bemelman, Willem
    d'Hoore, Andre
    Pellino, Gianluca
    Dignass, Axel U.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 (08): : 873 - 885
  • [3] Clinicians' adherence to European Crohn's and Colitis Organisation guidelines in the clinical care of adults with inflammatory bowel disease
    Jackson, B.
    Con, D.
    De Cruz, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S348 - S349
  • [4] Vedolizumab: Real-life outcomes to therapy in Crohn's disease
    Pulusu, S. S. R.
    Krishnaprasad, K.
    Cheng, D.
    Mogilevski, T.
    Flanagan, E.
    Parthasarathy, N.
    Wu, C.
    Prosser, R.
    Sawyer, E.
    Rizvi, Q. U. A.
    Taylor, K.
    Cooke, S.
    Mahy, G.
    Sparrow, M.
    Andrews, J.
    Connor, S.
    Bampton, P.
    Ghaly, S.
    Van Langenberg, D.
    Bell, S.
    De Cruz, P.
    Begun, J.
    Lawrance, I.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 143 - 143
  • [5] Gastroenterologists' Prescribing of Infliximab for Crohn's Disease: A National Survey
    St Charles, Meaghan
    Smith, Sheila R. Weiss
    Beardsley, Robert
    Fedder, Donald O.
    Carter-Pokras, Olivia
    Cross, Raymond K.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (10) : 1467 - 1475
  • [6] Ustekinumab induction effectiveness in Crohn's disease in a real-life cohort
    Sanchez Rodriguez, E.
    Mesonero Gismero, F.
    Lopez Sanroman, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S590 - S591
  • [7] Ustekinumab induction effectiveness in Crohn's disease in a real-life cohort
    Rullan, M.
    Elosua, A.
    Saldana, C.
    Amorena, E.
    Vicuna, M.
    Rubio, S.
    Nantes, O.
    Rodriguez, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S453 - S454
  • [8] 16th Congress of the European Crohn's and Colitis Organisation
    Brierley, Rob
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (09): : 696 - 697
  • [9] Ustekinumab Use in Crohn's Disease: Real-Life Canadian Experience
    Greenup, Astrid-Jane
    Rosenfeld, Greg
    Bressler, Brian
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S334 - S335
  • [10] European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly
    Sturm, Andreas
    Maaser, Christian
    Mendall, Michael
    Karagiannis, Dimitrios
    Karatzas, Pantelis
    Ipenburg, Nienke
    Sebastian, Shaji
    Rizzello, Fernando
    Limdi, Jimmy
    Katsanos, Konstantinos
    Schmidt, Carsten
    Jeuring, Steven
    Colombo, Francesco
    Gionchetti, Paolo
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 (03): : 263 - 273